Prevalence of venous thromboembolism in elective thoracic surgery;Prevalencia de la enfermedad tromboembólica venosa en cirugía torácica programada

Archivos de Bronconeumologia

Volumn 49, Issue 7, 2013, Pages 297-302

  Gómez Hernández, María Teresa ^a   Rodríguez Pérez, María ^a   Novoa Valentín, Nuria ^a   Jiménez López, Marcelo ^a   Aranda Alcaide, José Luis ^a   Varela Simó, Gonzalo ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Deep vein thrombosis; Lung resection; Pulmonary embolism; Thoracic surgery; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEEP VEIN THROMBOSIS; DESCRIPTIVE RESEARCH; ELECTIVE SURGERY; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; LUNG EMBOLISM; LUNG RESECTION; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; POSTOPERATIVE COMPLICATION; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; THORAX SURGERY; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM; ADOLESCENT; ADULT; CHILD; FEMALE; LUNG CANCER; LUNG LOBECTOMY; MALE; MIDDLE AGED; SEGMENTECTOMY; VERY ELDERLY;

ADOLESCENT; ADULT; AFTERCARE; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PNEUMONECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; PREMEDICATION; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; STOCKINGS, COMPRESSION; SURGICAL PROCEDURES, ELECTIVE; THORACIC SURGICAL PROCEDURES; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84879463703     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2013.01.011     Document Type: Article

References (20)

1. Burns P.J., Wilsom R.G., Cunningham C. Venous thromboembolism prophylaxis used by consultant general surgeons in Scotland. J R Coll Surg Edinb 2001, 46:329-333.
2. Kakkar A.K., Davidson B.L., Haas S.K. Compliance with recommended prophylaxis for venous thromboembolism: Improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost 2004, 2:221-227. the Investigators Against Thromboembolism (INATE) Core Group.
3. Donahue D.M. Pulmonary embolism prophylaxis: Evidence for utility in thoracic surgery. Thorac Surg Clin 2005, 15:237-242.
4. Otero Candelera R., Grau Segura E., Jiménez Castro D., Uresandi Romero F., López Villalobos J.L., Calderón Sandubete E., et al. Normativa SEPAR. Profilaxis de la enfermedad tromboembólica venosa. Arch Bronconeumol 2008, 44:160-169.
5. Ziomek S., Read R.C., Tobler H.G., Harrell J.E., Gocio J.C., Fink L.M., et al. Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg 1993, 56:223-226.
6. Nagasaki F., Flehinger B.J., Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest 1982, 82:25-29.
7. Kalweit G., Huwer H., Volkmer I., Petzold T., Gams E. Pulmonary embolism: A frequent cause of acute fatality after lung resection. Eur J Cardiothorac Surg 1996, 10:242-246.
8. Dentali F., Malato A., Ageno W., Imperatori A., Cajozzo M., Rotolo N., et al. Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg 2008, 135:705-706.
9. Guyatt G.H., Akl E.A., Crowther M., Gutterman D.D., Schuünemann H.J. Antithrombotic therapy and prevention of thrombosis American College of Chest Physicians evidence-based clinical practice guidelines (9th edition). Chest 2012, 141:7S-47S.
10. Spyropoulus A.C. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest 2005, 118:958-969.
11. Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005, 293:715-722.
12. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O'Fallon W.M., Melton L.J. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med 2000, 160:809-815.
13. Malgor R.D., Bilfinger T.V., Labropoulos N. A systematic review of pulmonary embolism in patients with lung cancer. Ann Thorac Surg 2012, 94:311-316.
14. De Martino R.R., Goodney P.P., Spangler E.L., Wallaert J.B., Corriere M.A., Rzucidlo E.M., et al. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg 2012, 55:1035-1040.
15. Lyman G.H., Khorana A.A., Falanga A., Clarke-Pearson D., Flowers C., Jahanzeb M., et al. American Society of Clinical Oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007, 25:490-505. American Society of Clinical Oncology.
16. Swiniarska J., Zÿekanowska E., Dancewicz M., Bella M., Szczesny T.J., Kowalewski J. Pneumonectomy due to lung cancer results in a more pronounced activation of coagulation system than lobectomy. Eur J Cardiothorac Surg 2009, 36:1064-1068.
17. Mason D.P., Quader M.A., Blackstone E.H., Rajeswaran J., DeCamp M.M., Murthy S.C., et al. Thromboembolism after pneumonectomy for malignancy: An independent marker of poor outcome. J Thorac Cardiovasc Surg 2006, 131:711-718.
18. Weder W., Collaud S., Eberhardt W.E., Hillinger S., Welter S., Stahel R., et al. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage iii non-small-cell lung cancer. J Thorac Cardiovasc Surg 2010, 139:1424-1430.
19. Bergqvist D., Agnelli G., Cohen A.T., Eldor A., Nilsson P.E., le Moigne-Amrani A., et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002, 346:975-980. ENOXACAN II Investigators.
20. Rasmussen M.S., Jorgensen L.N., Wille-Jørgensen P., Nielsen J.D., Horn A., Mohn A.C., et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: A multicenter randomized open-label study. J Thromb Haemost 2006, 4:2384-2390. FAME Investigators.